The Supreme Court questioned the Election Commission of India over allegations of voter roll manipulation, demanding accountability on electoral integrity. Separately, petitions challenging high prices of cancer drugs came before the courts, raising questions about drug price regulation under the Essential Commodities Act. Reservation jurisprudence resurfaced through legal challenges involving OBC and SC/ST quota implementation. These concurrent developments place constitutional bodies, drug pricing policy, and fundamental rights doctrine simultaneously under judicial scrutiny.

This news cluster touches three distinct but exam-critical static concepts.

**Election Commission and Voter Rolls:** The ECI is a constitutional body under Article 324, responsible for superintendence, direction, and control of elections. The Electoral Roll is governed by the Representation of the People Act, 1950. When the Supreme Court questions ECI's accountability, it tests the boundary between constitutional autonomy and judicial review — a recurring UPSC theme. The Model Code of Conduct, delimitation, and voter registration processes are all static hinterland here.

**Drug Price Regulation:** Cancer drug pricing falls under the Drugs (Prices Control) Order (DPCO), 2013, issued under the Essential Commodities Act, 1955. The National Pharmaceutical Pricing Authority (NPPA) is the regulatory body. The UPSC frequently tests which drugs are under price control, what mechanism sets the ceiling (market-based pricing for scheduled formulations), and which ministry oversees NPPA (Ministry of Chemicals and Fertilizers).

**Reservation Jurisprudence:** The constitutional basis for reservations lies in Articles 15(4), 15(5), 16(4), and 16(4A). The Supreme Court's landmark rulings — Indra Sawhney (1992) capping reservations at 50%, M. Nagaraj (2006) on creamy layer for SC/ST promotions, and Jarnail Singh (2018) — form the testable static core. Any new judicial challenge to OBC or SC/ST quotas reactivates these precedents for exam purposes.